Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-23-014865

SVP, General Counsel&Secretary sold 6,878 shares at $3.03 ($20,835)

  • SVP, General Counsel&Secretary acquired 70,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Mano Michael SVP, General Counsel&Secretary 2023-02-28 Grant or award +70,000 153,000 D: show line 1 in the form
Mano Michael SVP, General Counsel&Secretary 2023-03-01 Sale −6,878 $3.03 $20,835 146,122 D: show line 2 in the form
Open-market sales · 6,878 sh · avg $3.03 · $20,835
Loading xslF345X03/doc4.xml…